The Experts below are selected from a list of 24189 Experts worldwide ranked by ideXlab platform
Barrie Marmion - One of the best experts on this subject based on the ideXlab platform.
-
an economic evaluation of increased uptake in q fever vaccination among meat and agricultural industry workers following implementation of the national q fever management program
Australian and New Zealand Journal of Public Health, 2003Co-Authors: Michelle Kermode, Karen Yong, Susan F Hurley, Barrie MarmionAbstract:Introduction:Q fever is a serious but Vaccine-Preventable Infectious Disease that predominantly affects those working in the meat and agricultural industries. In October 2000, the Commonwealth Government introduced the National Q Fever Management Program. This economic evaluation assesses the cost-effectiveness and cost-utility of improved vaccine uptake among meat and agricultural industry workers. Methods:Separate analyses were conducted for meat and agricultural industry workers. Clinical and epidemiological data used to create the models were obtained from published sources. Markov modelling was used to estimate the impact of Q fever vaccination uptake on the direct costs and outcomes of Q fever over a 20-year period. Results:Increasing vaccine uptake from 65% to 100% among meat industry workers results in an incremental cost per life year gained of $20,002, and a cost per QALY of $6,294. Increasing vaccine uptake from zero to 20% among agricultural industry workers results in an incremental cost per life year gained of $24,950, and a cost per QALY of $7,984. Including some indirect costs in the form of Workcover payments results in cost savings for both industry groups. Conclusion:The results of this evaluation indicate that public health strategies to enhance the uptake of Q fever vaccine among high-risk workers potentially provides excellent value for the money invested.
Michelle Kermode - One of the best experts on this subject based on the ideXlab platform.
-
an economic evaluation of increased uptake in q fever vaccination among meat and agricultural industry workers following implementation of the national q fever management program
Australian and New Zealand Journal of Public Health, 2003Co-Authors: Michelle Kermode, Karen Yong, Susan F Hurley, Barrie MarmionAbstract:Introduction:Q fever is a serious but Vaccine-Preventable Infectious Disease that predominantly affects those working in the meat and agricultural industries. In October 2000, the Commonwealth Government introduced the National Q Fever Management Program. This economic evaluation assesses the cost-effectiveness and cost-utility of improved vaccine uptake among meat and agricultural industry workers. Methods:Separate analyses were conducted for meat and agricultural industry workers. Clinical and epidemiological data used to create the models were obtained from published sources. Markov modelling was used to estimate the impact of Q fever vaccination uptake on the direct costs and outcomes of Q fever over a 20-year period. Results:Increasing vaccine uptake from 65% to 100% among meat industry workers results in an incremental cost per life year gained of $20,002, and a cost per QALY of $6,294. Increasing vaccine uptake from zero to 20% among agricultural industry workers results in an incremental cost per life year gained of $24,950, and a cost per QALY of $7,984. Including some indirect costs in the form of Workcover payments results in cost savings for both industry groups. Conclusion:The results of this evaluation indicate that public health strategies to enhance the uptake of Q fever vaccine among high-risk workers potentially provides excellent value for the money invested.
Karen Yong - One of the best experts on this subject based on the ideXlab platform.
-
an economic evaluation of increased uptake in q fever vaccination among meat and agricultural industry workers following implementation of the national q fever management program
Australian and New Zealand Journal of Public Health, 2003Co-Authors: Michelle Kermode, Karen Yong, Susan F Hurley, Barrie MarmionAbstract:Introduction:Q fever is a serious but Vaccine-Preventable Infectious Disease that predominantly affects those working in the meat and agricultural industries. In October 2000, the Commonwealth Government introduced the National Q Fever Management Program. This economic evaluation assesses the cost-effectiveness and cost-utility of improved vaccine uptake among meat and agricultural industry workers. Methods:Separate analyses were conducted for meat and agricultural industry workers. Clinical and epidemiological data used to create the models were obtained from published sources. Markov modelling was used to estimate the impact of Q fever vaccination uptake on the direct costs and outcomes of Q fever over a 20-year period. Results:Increasing vaccine uptake from 65% to 100% among meat industry workers results in an incremental cost per life year gained of $20,002, and a cost per QALY of $6,294. Increasing vaccine uptake from zero to 20% among agricultural industry workers results in an incremental cost per life year gained of $24,950, and a cost per QALY of $7,984. Including some indirect costs in the form of Workcover payments results in cost savings for both industry groups. Conclusion:The results of this evaluation indicate that public health strategies to enhance the uptake of Q fever vaccine among high-risk workers potentially provides excellent value for the money invested.
Susan F Hurley - One of the best experts on this subject based on the ideXlab platform.
-
an economic evaluation of increased uptake in q fever vaccination among meat and agricultural industry workers following implementation of the national q fever management program
Australian and New Zealand Journal of Public Health, 2003Co-Authors: Michelle Kermode, Karen Yong, Susan F Hurley, Barrie MarmionAbstract:Introduction:Q fever is a serious but Vaccine-Preventable Infectious Disease that predominantly affects those working in the meat and agricultural industries. In October 2000, the Commonwealth Government introduced the National Q Fever Management Program. This economic evaluation assesses the cost-effectiveness and cost-utility of improved vaccine uptake among meat and agricultural industry workers. Methods:Separate analyses were conducted for meat and agricultural industry workers. Clinical and epidemiological data used to create the models were obtained from published sources. Markov modelling was used to estimate the impact of Q fever vaccination uptake on the direct costs and outcomes of Q fever over a 20-year period. Results:Increasing vaccine uptake from 65% to 100% among meat industry workers results in an incremental cost per life year gained of $20,002, and a cost per QALY of $6,294. Increasing vaccine uptake from zero to 20% among agricultural industry workers results in an incremental cost per life year gained of $24,950, and a cost per QALY of $7,984. Including some indirect costs in the form of Workcover payments results in cost savings for both industry groups. Conclusion:The results of this evaluation indicate that public health strategies to enhance the uptake of Q fever vaccine among high-risk workers potentially provides excellent value for the money invested.
Anupam B Kharbanda - One of the best experts on this subject based on the ideXlab platform.
-
vaccine preventable hospitalizations among american indian alaska native children using the 2012 kid s inpatient database
Vaccine, 2018Co-Authors: Amanda J Nickel, Susan E Puumala, Anupam B KharbandaAbstract:Abstract Our aim was to assess the odds of hospitalization for a Vaccine-Preventable, Infectious Disease (VP-ID) in American Indian/Alaska Native (AI/AN) children compared to other racial and ethnic groups using the 2012 Kid’s Inpatient Database (KID) The KID is a nationally representative sample, which allows for evaluation of VP-ID in a non-federal, non-Indian Health Service setting. In a cross-sectional analysis, we evaluated the association of race/ethnicity and a composite outcome of hospitalization due to Vaccine-Preventable infection using multivariate logistic regression. AI/AN children were more likely (OR = 1.81, 95% CI = 1.34, 2.45) to be admitted to the hospital in 2012 for a VP-ID compared to Non-Hispanic white children after adjusting for age, sex, chronic Disease status, metropolitan location, and median household income. This disparity highlights the necessity for a more comprehensive understanding of immunization and Infectious Disease exposure among American Indian children, especially those not covered or evaluated by Indian Health Service.
